The DOI matches its Crossref record.
Progression of Incipient Diabetic Retinopathy During Good Glycemic Control
Abstract
To assess the extent to which the progression of diabetic retinopathy can be arrested by improved glycemic control, 35 normal dogs were randomly divided into a nondiabetic and three alloxan-induced diabetic groups prospectively identified according to glycemic control: poor control for 5 yr (PC), good control for 5 yr (GC), and poor control for 2.5 yr followed by good control for 2.5 yr (PGC). To achieve good control, insulin was given twice daily together with a measured diet so that hyperglycemia and glucosuria were mild and infrequent, and HbA1 was comparable to normal. Retinal capillary aneurysms and other lesions developed during 60 mo of poor control (group PC) and were inhibited if good control was begun promptly within 2 mo (group GC). In group PGC, retinopathy was absent or equivocal at 2.5 yr of poor control and, surprisingly, was found to develop subsequently despite good glycemic control. Retinopathy in group PGC was greater at autopsy than at 2.5 yr and was greater than in group GC. The results indicate that retinopathy may be preventable but tends to resist arrest even in its incipient stages, before more than the first few aneurysms have appeared.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hyperglycemic memory was first described in humans as the resistance to preventing the development of diabetic retinopathy despite achieving good glycemic control in patients (189).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [189]
Citations
Cited by
Sorted by citations
Items 301–400 of 468
Extrinsic and intrinsic factors influencing metabolic memory in type 2 diabetes
Vasishta, S., Umakanth, S., Adiga, P. K., & Joshi, M. B. (2021) · Vascular Pharmacology · doi:10.1016/j.vph.2021.106933 · Cited by 21
Sarras, M. P., Leontovich, A. A., & Intine, R. V. A. (2015) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2015.07.001 · Cited by 22
“Dog [Engerman and Kern, 1987] (12) Alloxan-induced diabetes (DM) 1) 5 yrs poor glycemic control (PGC) using insulin & 5 yr glycemic control (GGC) using insulin or 2) 2.”
BackgroundMethodInfluentialRecent Developments in the Understanding and Management of Diabetic Retinopathy
Klein, R. (1988) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30715-5 · Cited by 20
Dopamine ameliorates hyperglycemic memory‐induced microvascular dysfunction in diabetic retinopathy
Lee, Y., Jeon, H., Lee, A.-J., Kim, M., & Ha, K. (2022) · The FASEB Journal · doi:10.1096/fj.202200865r · Cited by 19
Hu, G., Ma, Y., Guo, Y. A., et al. (2009) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2009.06.007 · Cited by 19
Diabetic Retinopathy and Nephropathy
Klein, R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-153-6_27 · Cited by 20
“This is supported by data from animal models of experimental diabetes in which hyperglycemia results in retinopathy ( 20 ) ,i n epidemiological studies that demonstrate strong dose–response relationships of the incidence and progression of diabetic retinopathy to hyperglycemia (21), and in randomized Diabetic Retinopa…”
MethodIn Vivo Models of Diabetic Retinopathy
Kern, T. S. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-563-3_5 · Cited by 18
Self-citationEffects of Hyperglycemia on Vascular Smooth Muscle Ca2+Signaling
El‐Najjar, N., Kulkarni, R., Nader, N., Hodeify, R. F., & Machaca, K. (2017) · BioMed Research International · doi:10.1155/2017/3691349 · Cited by 17
The Legacy Effect in the Prevention of Cardiovascular Disease
Esmel, E. V., Naval-Álvarez, J., & Sacanella, E. (2020) · Nutrients · doi:10.3390/nu12113227 · Cited by 17
Response of Rat Retinal Capillary Pericytes and Endothelial Cells to Glucose
Makita, J., Hosoya, K., Zhang, P., & Kador, P. F. (2010) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2010.0051 · Cited by 17
“1,2 8 In addition to hyperglycemia, the establishment of tight glycemic control is also associated with deleterious effects because the administration of insulin or hyperglycemic drugs often results in acute glucose fluctuations and hypo-glycemia.”
Jeon, H., Moon, C., Kim, E.-B., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-02760-7 · Cited by 16
Genetics and Diabetic Retinopathy
Schwartz, S. G., Brantley, M. A., & Flynn, H. W. (2012) · Current Diabetes Reviews · doi:10.2174/157339913804143171 · Cited by 16
Willemsen, L., Neele, A. E., van der Velden, S., Prange, K. H. M., den Toom, M., van Roomen, C. P. A. A., Reiche, M. E., Griffith, G. R., Gijbels, M. J., Lutgens, E., et al. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000751 · Cited by 16
Raman, R., Verma, A., Pal, S. S., Gupta, A., Vaitheeswaran, K., & Sharma, T. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.01.006 · Cited by 16
“Researchers have conclusively proven, in the past, that once the retinopathy develops, there is no relationship between the level of glycemic control and the progression of DR, although the incidence of DR is significantly affected [29,30].”
Chen, S., Tang, Q., Wang, Y., Zheng, X., Chen, S., Sun, Y., Yao, W., & Gao, X. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.11.012 · Cited by 15
Complications of Diabetes Mellitus
Brownlee, M., Aiello, L. P., Cooper, M. E., Vinik, A. I., Nesto, R. W., & Boulton, A. J. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00033-x · Cited by 16
The Rationale for Glucose Control in Diabetes Mellitus
Nathan, D. M. (1992) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30216-0 · Cited by 16
Kowluru, R. A., Mohammad, G., & Kumar, J. P. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03534-1 · Cited by 16
Ha, K. (2024) · Theranostics · doi:10.7150/thno.95742 · Cited by 15
Microvascular Complications in the Eye: Diabetic Retinopathy
Bosma, E. K., Noorden, C. J. F. V., Klaassen, I., & Schlingemann, R. O. (2018) · Springer eBooks · doi:10.1007/978-3-319-93521-8_19 · Cited by 16
Diabetic polyneuropathy in the elderly
Beghi, E., Monticelli, M. L., & the Italian General Practitioner Study Group (IGPSG) (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1997.tb00273.x · Cited by 15
Gao, X., Kuang, H., Zou, W., et al. (2008) · Molecular Biology Reports · doi:10.1007/s11033-008-9407-0 · Cited by 15
“In animal models of DR, retinal dysmetabolism continued to progress after hyperglycemia was corrected in dogs [ 6 ].”
BackgroundThe epigenetic regulation of podocyte function in diabetes
Majumder, S., & Advani, A. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.07.015 · Cited by 15
Efficacy of treatment after measurable diabeticlike retinopathy in galactose-fed rats.
Robison, W. G., Laver, N., JACOT, J. L., et al. (1997) · PubMed · Cited by 15
Santiago, J. V. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.4.1400891 · Cited by 15
Epigenetic modifications and diabetic nephropathy
Reddy, M. A., Park, J. T., & Natarajan, R. D. (2012) · Kidney Research and Clinical Practice · doi:10.1016/j.krcp.2012.07.004 · Cited by 17
“Proc Natl Acad Sci U S A 105:9047–9052, 2008 [79] Engerman RL, Kern TS: Progression of incipient diabetic retinopathy during good glycemic control.”
BackgroundEffect of Diabecon (D-400), an Ayurvedic Herbomineral Formulation on Diabetic Retinopathy
Sharma, S., & Kulkarni, K. S. (2002) · Cited by 14
Frank, R. N. (1995) · Archives of Ophthalmology · doi:10.1001/archopht.1995.01100030029016 · Cited by 14
Aldose reductase inhibitors and cataract
Crabbe, M. J. C. (1991) · International Ophthalmology · doi:10.1007/bf00150976 · Cited by 14
“The risk of complications is considerably lowered if blood glucose control is normal [ 22 , 50].”
BackgroundThe Treatment of Diabetic Retinopathy: A View for the Internist
Raskin, P., & Arauz-Pacheco, C. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-226 · Cited by 14
Pancreatic and islet transplantation
Rosenberg, L. C. (2000) · Current Gastroenterology Reports · doi:10.1007/s11894-000-0101-1 · Cited by 14
Zimmerman, B. R. (1989) · Drugs · doi:10.2165/00003495-198938060-00006 · Cited by 14
Ocular manifestations of endocrine disease.
Plummer, C. E., Specht, A. J., & Gelatt, K. N. (2007) · PubMed · Cited by 13
Yue, D. K., McLennan, S. V., & Turtle, J. R. (1992) · Diabetic Medicine · doi:10.1111/j.1464-5491.1992.tb01765.x · Cited by 13
Manifestations of systemic disease in the retina and fundus of cats and dogs
Beckwith‐Cohen, B., & Petersen‐Jones, S. M. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1337062 · Cited by 16
“By contrast, the development of retinopathy could be inhibited with improved glycemic control in a canine model of diabetic retinopathy (63).”
BackgroundLeontovich, A. A., Intine, R. V. A., & Sarras, M. P. (2016) · Journal of Diabetes Research · doi:10.1155/2016/2860780 · Cited by 12
“Additionally, this persistence in diabetic tissue deficits has also been supported by multiple lines of experimental laboratory evidence [3, 9–13] and collectively, these data indicate that the initial hyperglycemic period results in permanent abnormalities in the target organs.”
Preventing Long Term Complications
Zimmerman, B. R. (1992) · Drugs · doi:10.2165/00003495-199200443-00008 · Cited by 12
Borderie, G., Foussard, N., Larroumet, A., Blanco, L., Barbet‐Massin, M., Ducos, C., Arab, L. R., Domenge, F., Mohammedi, K., Ducasse, É., et al. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108595 · Cited by 11
The effects of metformin on maternal haemodynamics in gestational diabetes mellitus: A pilot study
Osman, M. W., Nath, M., Khalil, A. A., Webb, D. R., Robinson, T. G., & Mousa, H. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.003 · Cited by 11
Proliferative Diabetic Retinopathy
Davis, M. D., & Blodi, B. A. (2006) · Elsevier eBooks · doi:10.1016/b978-0-323-02598-0.50074-4 · Cited by 12
Legacy in Cardiovascular Risk Factors Control: From Theory to Future Therapeutic Strategies?
Pothen, L., & Balligand, J. (2021) · Antioxidants · doi:10.3390/antiox10111849 · Cited by 11
“observed that animals with late onset optimization of glycemic control had a higher incidence of progression of this microvascular complication of diabetes [22].”
BackgroundMetabolic memory and diabetic retinopathy: Legacy of glycemia and possible steps into future
Sheemar, A., Bellala, K., Sharma, S. V., Sharma, S., Kaur, I., Rani, P. K., Sivaprasad, S., Narayan, K. M. V., Das, T., & Takkar, B. (2024) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_2563_23 · Cited by 11
“Engerman and Kern [36] studied MM in DR by evaluating the effect of reversal of PC in dogs.”
BackgroundSyntaxin 17 Translocation Mediated Mitophagy Switching Drives Hyperglycemia‐Induced Vascular Injury
Luo, A., Wang, R., Gong, J., Wang, S., Yun, C., Chen, Z., Jiang, Y., Liu, X., Dai, H., Liu, H., et al. (2025) · Advanced Science · doi:10.1002/advs.202414960 · Cited by 10
Involvement of advanced glycation end‐products in ‘hyperglycemic memory’
Nishikawa, T., & Araki, E. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12405 · Cited by 10
A primer on metabolic memory: why existing diabesity treatments fail
Çöpür, S., Rossing, P. R., Afşar, B., Sag, A. A., Siriopol, D. C., Kuwabara, M., Ortíz, A., & Kanbay, M. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfaa143 · Cited by 10
“Engerman and Kern [4], a relatively long time ago, described that diabetic retinopathy progressed despite good glycaemic control in dogs and coined the term metabolic memory.”
BackgroundDiabetische Retinopathie und Makulopathie
Lemmen, K. D., & Martin, S. (2008) · Der Diabetologe · doi:10.1007/s11428-008-0220-0 · Cited by 9
Old and New Biomarkers Associated with Endothelial Dysfunction in Chronic Hyperglycemia
BALDASSARRE, M. P. A., Pipino, C., Pandolfi, A., Consoli, A., Pietro, N. D., & Formoso, G. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/7887426 · Cited by 10
“5 years and then returned to normal blood glucose levels versus nondiabetic and diabetic dogs [63].”
Feasibility and Efficacy of Intensive Insulin Therapy in Type 1 Diabetes Mellitus in Primary Care
Fasching, P., Derfler, K., Maca, T., Kurzemann, S., Howorka, K., Schneider, B., Zirm, M. E., & Waldhäusl, W. K. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00365.x · Cited by 10
Workshop VIII—Retinopathy, nephropathy, neuropathy, and tight control
Lebovitz, C.-C. H. E., & Vinik, C.-C. A. I. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90045-y · Cited by 10
The relationship between metabolic control and vascular complications of diabetes mellitus.
Godine, J. E. (1988) · The Medical clinics of North America · doi:10.1016/s0025-7125(16)30706-4 · Cited by 12
Kumar, J. P., Malaviya, P. B., & Kowluru, R. A. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.70009 · Cited by 11
“Using experimental models of diabetic retinopathy-metabolic memory, LncRNA array was performed in the retina of rats in poor glycemic control for 8 months, or in poor control for 4 months, followed by good glycemic control for four additional months.”
Role of Advanced Glycation End Products in the Progression of Diabetes Mellitus
Xu, Y., & Guo, H. (2017) · Global Journal of Obesity Diabetes and Metabolic Syndrome · doi:10.17352/2455-8583.000019 · Cited by 9
“It is reported in diabetic dogs that euglycemia could not inhibit the progression of diabetic microvascular dysfunction, thus scholars named this phenomenon as “hyperglycemic memory” [70-72].”
BackgroundEnninga, E. A. L., Egan, A. M., Alrahmani, L., Leontovich, A. A., Ruano, R., & Sarras, M. P. (2019) · Journal of Diabetes Research · doi:10.1155/2019/9583927 · Cited by 9
Microvascular disease in diabetes mellitus.
Kollros, P. R., & Konkle, B. A. (1997) · PubMed · Cited by 9
Atkinson, M. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00032-0 · Cited by 8
Insights into the Role of DNA Methylation and Protein Misfolding in Diabetes Mellitus
Ahmed, S. M., Johar, D., Ali, M. M., & El‐Badri, N. (2019) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530319666190305131813 · Cited by 9
Endothelial function can be modulated by acute hyperglycemia
Qambari, H., Yu, P. K., Balaratnasingam, C., Dickson, J., & Yu, D. (2025) · Scientific Reports · doi:10.1038/s41598-025-12612-4 · Cited by 8
Polyol Effects on Growth Factors and MAPK Signaling in Rat Retinal Capillary Cells
Zhang, P., Zhang, Z., & Kador, P. F. (2013) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2013.0170 · Cited by 7
Aoki, E., Hirashima, T., Kumamoto, Y., et al. (2022) · Diabetology International · doi:10.1007/s13340-022-00608-8 · Cited by 7
“A history of previous hyperglycemia or strict glycemic control, known as metabolic memory [6, 7] or legacy effects [8], may promote or suppress the subsequent development of cardiovascular disease (CVD).”
BackgroundMetabolic Memory in Diabetes Is True Long-term Memory
Frank, R. N. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2008.607 · Cited by 7
Diabetes and Long-Term Complications
Cagliero, E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00051-2 · Cited by 7
Torpid Diabetic Wound Healing: Evidence on the Role of Epigenetic Forces
Berlanga‐Acosta, J. (2015) · International Journal of Diabetes and Clinical Research · doi:10.23937/2377-3634/1410020 · Cited by 7
“Although the study by Engerman and Kern in 1987 [25] was seminal to shape the future concept of metabolic memory relevant to cutaneous wound healing, the first evidence supporting the metabolic memory concept, emerged from the classic experiment developed by Vracko and Benditt.”
BackgroundRetinal Capillary Dilation: Early Diabetic-Like Retinopathy in the Galactose-Fed Rat Model
Glover, J. P., JACOT, J. L., Basso, M., et al. (2000) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2000.16.167 · Cited by 7
Mechanisms and strategies for prevention in diabetic retinopathy
Lorenzi, M. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0019-6 · Cited by 6
“Landmark studies by Engerman and Kern [ 7 ] showed progression of retinopathy in diabetic dogs that had been hyperglycemic for 2.5 years but had been returned to near normoglycemia for another 2.5 years before manifesting any measurable retinal microangiopathy; and studies by our laboratory showed that diabetes in viv…”
BackgroundInfluentialVasishta, S., Poojary, G., Sharma, S., Gomes, S. M., Bhat, S. M., Mallya, S. P., Adiga, P. K., Umakanth, S., Jakati, S., Takkar, B., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202502260rr · Cited by 7
“A 5-year study on dogs revealed that immediate glycemic control after hyperglycemic insult reduced the onset of diabetic retinopathy [6].”
The Role of Nonenzymatic Post-translational Protein Modifications in Uremic Vascular Calcification
Lim, K. J., & Kalim, S. (2019) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2019.10.001 · Cited by 6
Reducing cardiovascular risk in diabetes
Marre, M. (2007) · Journal of Hypertension · doi:10.1097/01.hjh.0000271505.69949.9d · Cited by 6
Ethical Issues Involved in the Development of Animal Models for Type I Diabetes
Sieber, F. E., & Traystman, R. J. (1993) · ILAR Journal · doi:10.1093/ilar.35.1.19 · Cited by 6
“Models using streptozotocin-induced type I diabetes have been useful in studying the effects of tight versus loose control of blood glucose level on the development of diabetic retinopathy (Engerman and Kern, 1987), examining changes in kidney basement membrane associated with the development of diabetic nephropathy (…”
The Pathophysiology of Diabetes Mellitus: An Update
HERNANDEZ, C. G. (1989) · The Science of Diabetes Self-Management and Care · doi:10.1177/014572178901500217 · Cited by 6
Durability of Glycemic Control: A Feature of the Thiazolidinediones
Serdy, S., & Abrahamson, M. J. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/152091504773731366 · Cited by 6
Why do some diabetics develop severe microvascular complications?
Tchobroutsky, G. (1989) · Journal of Diabetes and its Complications · doi:10.1016/0891-6632(89)90002-0 · Cited by 6
Tight Glycaemic Control Prevents Diabeticcomplications
Pirart, J. (1995) · Acta Clinica Belgica · doi:10.1080/17843286.1995.11718471 · Cited by 6
Normoglykämie als Therapieziel der Diabetesbehandlung — Konzept und Realisierung
Siegel, E. G. (1990) · Journal of Molecular Medicine · doi:10.1007/bf01649021 · Cited by 6
“[19, 49]) und grogen prospektiven Verlaufskontrollen bei Diabetikern (z.”
BackgroundVascular damage in diabetic retinopathy
Kern, T. S., & Huang, S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-7020-2983-7.00065-6 · Cited by 4
Self-citationNeubauer‐Geryk, J., Wielicka, M., Myśliwiec, M., Zorena, K., & Bieniaszewski, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063190 · Cited by 6
“The concept of metabolic memory refers to the long-term benefits of achieving early glycemic control as well as the negative impact of hyperglycemia, including the development and progression of complications in diabetic patients [1].”
BackgroundAnimal Models of Diabetic Retinopathy
Chen, M., & Stitt, A. W. (2015) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-3-319-19434-9_5 · Cited by 5
Emerging therapeutics for diabetic retinopathy: potential therapies for the new millennium
JACOT, J. L., & Sredy, J. (1999) · Emerging Therapeutic Targets · doi:10.1517/14728222.3.2.307 · Cited by 5
Dissociation of Retinopathy and Nephropathy in Animal Models of Diabetes: Diabetes vs Galactosemia
Engerman, R. L., & Kern, T. S. (1992) · Springer eBooks · doi:10.1007/978-1-4614-7524-8_8 · Cited by 5
Self-citationJACOT, J. L., Laver, N., Glover, J. P., et al. (1996) · PubMed · Cited by 5
Complications of Diabetes in Childhood
Hamilton-Shield, J. P., & Baum, J. D. (1993) · Diabetic Medicine · doi:10.1111/j.1464-5491.1993.tb00109.x · Cited by 5
Pregnancy and Diabetic Retinopathy
Forrester, J. V., Towler, H. M. A., & Pearson, D. W. M. (1989) · Springer eBooks · doi:10.1007/978-1-4471-1680-6_17 · Cited by 5
Endocrinological aspects of managing patients after total duodenopancreatectomy
Lebedeva, A. N., & Vishnevsky, V. A. (2020) · Annaly khirurgicheskoy gepatologii = Annals of HPB surgery · doi:10.16931/1995-5464.2020396-111 · Cited by 4
“Феномен метаболической памяти В основе гипотезы метаболической памяти лежит представление о том, что ранний гликемический фон “запоминается” в тканях и органах-мишенях (сетчатка, почки, сердце, периферические нервы) [69].”
Remodeling is at the heart of chromatin
El‐Osta, A. (2011) · Epigenetics · doi:10.4161/epi.6.7.16551 · Cited by 4
“With the ongoing debate on the benefit of continued monitoring individuals of the DCCT research group13 in the late 1980s, there was emerging evidence of the effects of glycemic memory published by Engerman and Kern.10 Several years later the authors Roy et al. published their findings on the phenomenon of hyperglycem…”
BackgroundInfluentialMortality risk in admitted patients with diabetes mellitus according to treatment
Akirov, A., Dicker, D., Shochat, T., & Shimon, I. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.04.011 · Cited by 4
Genetic and chemically-induced Zebrafish models for the study of diabetes mellitus
Sarras, M. P. (2018) · MOJ Anatomy & Physiology · doi:10.15406/mojap.2018.05.00217 · Cited by 4
Zawada, A. E., Naskręt, D., Niedźwiecki, P., Grzymislawski, M. B., Zozulińska‐Ziółkiewicz, D., & Dobrowolska, A. (2020) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/126050 · Cited by 4
Diabetische Retinopathie und Makulopathie
Hammes, H. (2011) · Der Internist · doi:10.1007/s00108-010-2762-7 · Cited by 4
Why Should We Treat Hyperglycaemia?
Pelkonen, R. (1990) · Annals of Medicine · doi:10.3109/07853899009147271 · Cited by 4
Perspectives in Diabetes Pathogenesis of Diabetic Retinopathy
Engerman, R. L. (1989) · Cited by 4
Self-citationOcular Disease in the Diabetic Elderly
Kincaid, M. C. (1999) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30060-0 · Cited by 4
AMPK as a central regulator of metabolic memory: mechanisms and therapeutic opportunities
Khan, W. A., Garg, S. S., Banyal, K., & Gupta, J. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-01859-x · Cited by 4
Mémoire métabolique : Comment l’expliquer ? Quelles sont les preuves ?
Larger, É., Lemoine, A., & Faucher, P. (2015) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(15)30008-0 · Cited by 4
King, G. L., Shiba, T., Feener, E. P., & Nayak, R. C. (1992) · Springer eBooks · doi:10.1007/978-1-4614-7524-8_9 · Cited by 3
Chronic Diabetic Complications: Endothelial Cells at the Frontline
Khan, Z. A., & Chakrabarti, S. (2010) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/978160805160111001010121 · Cited by 3
Yue, D. K., Capogreco, C., McLennan, S. V., et al. (1989) · Diabetic Medicine · doi:10.1111/j.1464-5491.1989.tb01214.x · Cited by 3
Impaired Efferocytosis of Pericytes and Vascular Smooth Muscle Cells in Diabetic Retinopathy
Gardiner, T. A., Little, K., & Stitt, A. W. (2025) · Cells · doi:10.3390/cells14171349 · Cited by 2
“This is especially true in diabetic patients for whom hyperglycemia is episodic, unlike the unremitting high-glucose environment of the animal models in which metabolic memory was characterized [202,205].”
Tonade, D., & Kern, T. S. (2017) · Experimental Eye Research · doi:10.1016/j.exer.2017.07.009 · Cited by 2
“We previously conducted 5 year studies of diabetic dogs to investigate the roles of glycemic control (Howell et al., 2013; Engerman and Kern, 1987) or experimental therapies (Kern and Engerman, 2001; Engerman and Kern, 1993) on the development of diabetic retinopathy, and showed that PC or MC…”
BackgroundSelf-citationGandhi, T., Patel, A., & Purohit, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90583-1.00034-9 · Cited by 2
Grading of Diabetic Retinopathy
Larsen, M., Soliman, W. M., Kern, T. S., Mohr, S., Girach, A., Fong, D. S., Lang, G. E., Helbig, H., Joussen, A. M., Adamis, A. P., et al. (2007) · Springer eBooks · doi:10.1007/978-3-540-29542-6_19 · Cited by 2
Self-citationInsulin Treatment in the Elderly Diabetic Patient
Nathan, D. M. (1990) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30589-5 · Cited by 2
Metadata
- Authors
- Engerman, R. L., & Kern, T. S.
- Affiliations
- University of Wisconsin–Madison (US)
- ORCID
- Kern, Timothy S
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1987-07-01
- Volume
- 36
- Issue
- 7
- Pages
- 808-812
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2104738423
- Cited by
- 490
- References
- 0
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 15 · 2023: 13 · 2022: 12 · 2021: 13 · 2020: 13 · 2019: 16 · 2018: 11 · 2017: 16 · 2016: 14 · 2015: 25 · 2014: 26 · 2013: 22 · 2012: 17
- FWCI
- 13.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Eye Institute (EY00 300)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Keywords
- diabetic retinopathy, disease progression, glycemic control, alloxan-induced diabetes, insulin therapy, HbA1c, glycosuria, retinopathy prevention, dogs
- MeSH terms
- Aneurysm, Animals, Autopsy, Blood Glucose, Capillaries, Diabetic Retinopathy, Dogs, Female, Hyperglycemia, Insulin, Male, Retina
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review